PMGC Holdings Inc. (ELAB)
PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering engineered probiotic designed to tackle the critical challenge of maintaining muscle mass during weight reduction regimens, especially those utilizing GLP-1 receptor agonists. Beyond its core operations, the company also engages in medical scientific research and development and manages various investment firms. Formerly known as Elevai Labs, Inc., the organization adopted its current name, PMGC Holdings Inc., in December 2024. Established in 2020, PMGC Holdings Inc. maintains its headquarters in Newport Beach, California.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
PMGC Holdings Inc.
No short interest data available.
Past the 1:250 Nasdaq cap, ineligible for a bid-price compliance period
- 1:10Reverse splitAug 21, 202610 shares → 1
- 1:6Reverse splitMar 10, 20266 shares → 1
- 1:4Reverse splitJan 6, 20264 shares → 1
- 1:3.5Reverse splitSep 2, 20253.5 shares → 1
- 1:7Reverse splitMar 10, 20257 shares → 1
- 1:200Reverse splitNov 27, 2024200 shares → 1
- 2:1Forward splitJun 2, 20041 share → 2
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Revenue | $590K | $2.47M | $0 | $766K | $827 | $0 |
| YoY Growth | -76.1% | - | - | 92557.4% | - | - |
| Cost of Revenue | $515K | $670K | $554 | $319K | $88 | $0 |
| Gross Profit | $75K | $1.8M | -$554 | $447K | $739 | $0 |
| Gross Margin | 12.7% | 72.8% | - | 58.4% | 89.4% | - |
| Research and Development | $147K | $105K | $7K | $229K | $124K | $119K |
| Selling, General, and Administrative | $1.62M | $856K | $1.13M | $1.73M | $634K | $103K |
| Other | $5.68M | $2.7M | $0 | $277K | $28K | $0 |
| Total Operating Expenses | $7.45M | $3.66M | $1.14M | $2.24M | $786K | $222K |
| Operating Income (EBIT) | -$7.38M | -$1.87M | -$1.14M | -$1.79M | -$785K | -$222K |
| Operating Margin | -1250.1% | -75.7% | - | -233.4% | -94928.9% | - |
| Interest Expense | $547K | $735K | $0 | $3K | $0 | $0 |
| Interest Income | $118K | $13K | $6K | $8K | $0 | $0 |
| Other Income (Expense) | -$373K | -$2.15M | -$516K | -$12K | $323 | -$1K |
| Income Before Tax (EBT) | -$7.75M | -$4.02M | -$1.66M | -$1.8M | -$785K | -$223K |
| Income Tax Expense | $31K | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$7.71M | -$6.25M | -$4.3M | -$1.8M | -$785K | -$223K |
| Net Income Margin | -1306.3% | -253.1% | - | -234.9% | -94889.8% | - |
| Supplementary Data | ||||||
| EPS | -3787.40 | -65923.20 | -477946.33 | -158.40 | -887.71 | -19.79 |
| Diluted EPS | -3787.40 | -65923.20 | -1511.43 | -158.40 | -887.71 | -19.79 |
| Weighted Average OS | 2,035 | 95 | 9 | 11,344 | 884 | 11,263 |
| EBITDA | -$7.27M | -$3.27M | -$1.13M | -$1.79M | -$782K | $0 |
| EBITDA Margin | -1231.4% | -132.5% | - | -233.7% | -94556.5% | - |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Assets | ||||||
| Current Assets | ||||||
| Cash and Cash Equivalents | $5.4M | $3.98M | $3.33M | $1.15M | $412K | $13K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $5.4M | $3.98M | $3.33M | $1.15M | $412K | $13K |
| Accounts Receivable | $341K | $5K | $36K | $13K | $2K | $371 |
| Inventory | $95K | $1K | $496K | $230K | $161K | $0 |
| Other Current Assets | $1.03M | $1.19M | $0 | $0 | $0 | $0 |
| Total Current Assets | $6.87M | $6.05M | $4.92M | $1.55M | $637K | $17K |
| Long-Term Assets | ||||||
| Property, Plant & Equipment Net | $2.13M | $1K | $2K | $330K | $30K | $0 |
| Goodwill | $978K | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $2.89M | $2.8M | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $139K | $0 | $11K | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $269K | $0 | $0 | $0 |
| Total Long-Term Assets | $6M | $2.94M | $270K | $341K | $30K | $0 |
| Other Assets | $0 | $0 | $1 | $0 | $0 | $0 |
| Total Assets | $12.87M | $8.99M | $5.19M | $1.89M | $666K | $17K |
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts Payable | $698K | $481K | $596K | $211K | $98K | $154 |
| Short-Term Debt | $1.34M | $0 | $0 | $0 | $0 | $24K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $37K | $10K | $0 | $0 |
| Other Current Liabilities | $418K | $549K | $369K | $68K | $0 | $16K |
| Total Current Liabilities | $3.94M | $1.8M | $1.3M | $588K | $216K | $41K |
| Long-Term Liabilities | ||||||
| Long-Term Debt | $1.06M | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $31K | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $534K | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $1.09M | $534K | $65K | $173K | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $5.03M | $2.33M | $1.36M | $761K | $216K | $41K |
| Stockholders' Equity | ||||||
| Preferred Stock | $637 | $0 | $0 | $571 | $385 | $21 |
| Common Stock | $8 | $44 | $2K | $957 | $952 | $848 |
| Retained Earnings | -$21.02M | -$13.27M | -$7.02M | -$2.72M | -$922K | -$137K |
| Comprehensive Income & Other | -$2K | -$337 | $202 | $111 | $202 | -$1K |
| Other Stockholders' Equity | $28.85M | $19.93M | $10.85M | $3.85M | $1.37M | $113K |
| Total Equity | $7.84M | $6.66M | $3.83M | $1.13M | $451K | -$24K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $12.87M | $8.99M | $5.19M | $1.89M | $666K | $17K |
| Supplementary Data | ||||||
| Total Debt | $2.64M | $0 | $210K | $283K | $0 | $24K |
| Net Debt | -$2.76M | -$3.98M | -$3.12M | -$872K | -$412K | $11K |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Operating Activities | ||||||
| Net Income | -$7.75M | -$6.25M | -$4.3M | -$1.8M | -$785K | -$223K |
| Depreciation & Amortization | $111K | $13K | $12K | $7K | $3K | $222K |
| Deferred Income Tax | $31K | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | -$19K | $97K | $488K | $172K | $142K | $0 |
| Changes in Working Capital: | ||||||
| Accounts Receivable | -$101K | -$13K | -$23K | -$12K | -$1K | -$605 |
| Inventory | $148K | -$403K | -$266K | -$69K | -$161K | $0 |
| Accounts Payable | $958K | $207K | $467K | $65K | $192K | $0 |
| Other Working Capital | -$417K | $460K | -$1M | $28K | -$52K | $7K |
| Total Working Capital Change | $588K | $252K | -$823K | $12K | -$22K | $7K |
| Other Non-Cash Items | $1.1M | $397K | $69K | $24K | $600 | -$223K |
| Net Cash from Operating | -$5.93M | -$5.49M | -$4.56M | -$1.59M | -$661K | -$217K |
| Investing Activities | ||||||
| Capital Expenditures | -$448K | -$9K | -$11K | -$36K | -$32K | $0 |
| Acquisitions | -$2.16M | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$1.79M | -$139K | $0 | $0 | $0 | $0 |
| Sales of Investments | $1.76M | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | -$127K | -$462K | $0 | $4K | $0 | $0 |
| Net Cash from Investing | -$2.77M | -$611K | -$11K | -$32K | -$32K | $0 |
| Financing Activities | ||||||
| Debt Repaid | - | $236K | - | - | - | - |
| Common Stock Issuance | $6.13M | $6.99M | $7.46M | $25K | $0 | $115K |
| Common Stock Repurchases | -$179 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $3.99M | $0 | -$725K | $0 | $0 | $123K |
| Net Cash from Financing | $10.12M | $6.76M | $6.74M | $2.36M | $1.09M | $238K |
| Forex Effect | $177 | -$2K | $1K | -$1K | $1K | -$2K |
| Net Change in Cash | $1.42M | $658K | $2.17M | $743K | $399K | $20K |
| Supplementary Data | ||||||
| Operating Cash Flow | -$5.93M | -$5.49M | -$4.56M | -$1.59M | -$661K | -$217K |
| Capital Expenditure | -$448K | -$9K | -$11K | -$36K | -$32K | $0 |
| Free Cash Flow | -$6.38M | -$5.49M | -$4.57M | -$1.62M | -$693K | -$217K |
| Cash at Beginning | $3.98M | $3.33M | $1.15M | $412K | $13K | $0 |
| Cash at End | $5.4M | $3.98M | $3.33M | $1.15M | $412K | $20K |